| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/04/2000 | WO1999065452A9 Hydrogels of water soluble polymers crosslinked by protein domains |
| 05/04/2000 | WO1999064038A9 Novel analgesic agents |
| 05/04/2000 | WO1999064031A9 β2-ADRENERGIC RECEPTOR AGONISTS |
| 05/04/2000 | WO1999063988A9 Inhibitors of nitric oxide synthase |
| 05/04/2000 | WO1999061066A3 Convection-enhanced delivery of aav vectors |
| 05/04/2000 | WO1999059573A9 Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivatives and process for preparing the same |
| 05/04/2000 | WO1998025595A3 Aqueous drink composition comprising ibuprofen |
| 05/04/2000 | DE19850309A1 Expandierbares gastroretensives Therapiesystem mit verlängerter Magenverweildauer Expandable system gastroretensives therapy with prolonged gastric residence |
| 05/04/2000 | CA2347775A1 Process for producing spherical fine particles containing drug |
| 05/04/2000 | CA2347109A1 Fluticasone lotion having improved vasoconstrictor activity |
| 05/04/2000 | CA2347107A1 Bone-pathobolism treating agent |
| 05/04/2000 | CA2347032A1 O/w emulsion comprising an hydroxylated oil |
| 05/04/2000 | CA2347028A1 Systems and compounds for drug delivery to interstitial regions of the myocardium |
| 05/04/2000 | CA2346976A1 Chelating agents for radioimmunotherapy |
| 05/04/2000 | CA2346820A1 Preparation and use of solidified oils |
| 05/04/2000 | CA2344637A1 .delta.9 tetrahydrocannabinol (.delta.9 thc) solution metered dose inhalers and methods of use |
| 05/04/2000 | CA2344207A1 Biological material for preparing pharmaceutical compositions for treating mammals |
| 05/04/2000 | CA2343100A1 Method of making pressure sensitive adhesive matrix patches containing hydrophilic salts of drugs |
| 05/04/2000 | CA2340226A1 Preservative system for topically administrable pharmaceutical compositions |
| 05/04/2000 | CA2340225A1 Preservative system for topically administrable pharmaceutical compositions containing a fatty acid/amino acid soap |
| 05/03/2000 | EP0997153A1 Formulations for lipophilic compounds |
| 05/03/2000 | EP0997144A1 Plasticizer and patch containing the plasticizer |
| 05/03/2000 | EP0997143A2 Soft chewable tablets |
| 05/03/2000 | EP0996508A1 Film coatings and film coating compositions based on dextrin |
| 05/03/2000 | EP0996468A1 Conjugates of galactose-binding lectins and clostridial neurotoxins as analgesics |
| 05/03/2000 | EP0996467A1 Txu-7-pap immunotoxin and use thereof |
| 05/03/2000 | EP0996451A1 Triterpene saponin analogs having adjuvant and immunostimulatory activity |
| 05/03/2000 | EP0996442A1 Aqueous liquid pharmaceutical composition containing as main component benzopyran derivative |
| 05/03/2000 | EP0996437A1 Semisolid pharmaceutical formulation containing dexketoprofen trometamol |
| 05/03/2000 | EP0996436A1 Pharmaceutical formulations containing poorly soluble drug substances |
| 05/03/2000 | EP0996429A1 Solid state solutions and dispersions of poorly water soluble drugs |
| 05/03/2000 | EP0824354A4 Methods to inhibit late radiation-induced skin damage |
| 05/03/2000 | EP0682512B1 Alkaline ophthalmic suspensions |
| 05/03/2000 | EP0625055B1 Use of fullerenes in diagnostic and/or therapeutic agents |
| 05/03/2000 | EP0585436B1 Immobilization of chemical species in crosslinked matrices |
| 05/03/2000 | EP0383803B1 Oligonucleotide-polyamide conjugates |
| 05/03/2000 | CN1252005A Pressure-sensitive adhesives for percutaneous plasters and percutaneous plasters |
| 05/03/2000 | CN1252004A Base composition for percutaneous absorption and percutaneously absorbable preparation containing the base composition |
| 05/03/2000 | CN1252003A Solvent system for enhanced penetration of pharmaceutical compounds |
| 05/03/2000 | CN1252001A Method for destroying retinal pigment epithelial cells |
| 05/03/2000 | CN1251999A Stable extract of hypericum perforatum L.,method for producing same and corresponding pharmaceutical preparations |
| 05/03/2000 | CN1251986A Diffusional implantable delivery system |
| 05/03/2000 | CN1251969A Method for treating parillomarvirus infections |
| 05/03/2000 | CN1251773A Composition having silicone rubber stabilized ascorbic acid components |
| 05/03/2000 | CN1251745A Carotenoid preparation having mixture of beta-carotene, lycopene and xanthophyll |
| 05/02/2000 | US6057435 Nucleic acid coding for polypeptide which binds to receptor tyrosine kinase containing immunoglobulin-like and epidermal growth factor homology domains expressed in vascular endothelial cells; diagnosis/imaging; angiogenesis inhibition |
| 05/02/2000 | US6057429 Phosphatase activated crosslinking, conjugating and reducing agents; methods of using such agents; and reagents comprising phosphatase activated crosslinking and conjugating agents |
| 05/02/2000 | US6057374 Composition, device, and method for electrotransport agent delivery |
| 05/02/2000 | US6057364 Fluoro-substituted adamantane derivatives |
| 05/02/2000 | US6057292 Method for inhibiting growth hormone action |
| 05/02/2000 | US6057096 Photocleavable agents and conjugates for the detection and isolation of biomolecules |
| 05/02/2000 | US6056977 Once-a-day controlled release sulfonylurea formulation |
| 05/02/2000 | US6056975 Levothyroxine sodium, polysaccharide |
| 05/02/2000 | US6056966 Organic mono- or dinitrate in a pharmaceutically acceptable topical or parenteral carrier |
| 05/02/2000 | US6056955 Topical treatment of streptococcal infections |
| 05/02/2000 | US6056950 Ophthalmic solutions viscosified with tamarind seed polysaccharide |
| 05/02/2000 | US6056938 Cationic lipids and the use thereof |
| 05/02/2000 | CA2184242C Drug targeting system, method for preparing same and its use |
| 05/02/2000 | CA2104686C Delayed release oral dosage forms for treatment of intestinal disorders |
| 05/02/2000 | CA2076018C Docosahexaenoic acid, methods for its production and compounds containing the same |
| 04/27/2000 | WO2000023955A1 Virus-like particles for the induction of autoantibodies |
| 04/27/2000 | WO2000023601A1 Delivery system for porcine somatotropin |
| 04/27/2000 | WO2000023592A2 Minimal promoters and uses thereof |
| 04/27/2000 | WO2000023565A2 Novel neuropilin/growth factor binding and uses thereof |
| 04/27/2000 | WO2000023117A1 Photosensitizer conjugates for targeting intracellular pathogens |
| 04/27/2000 | WO2000023115A1 TREATMENT OF TRAUMA (I.E. GRAFT REJECTION) WITH LIPOSOMES CONTAINING DNA ENCODING FOR CTLA4Ig OR FOR ANTI-CD40L |
| 04/27/2000 | WO2000023114A2 Polymer conjugates of interferon beta- 1a and their uses |
| 04/27/2000 | WO2000023113A1 Peptide-based carrier devices for stellate cells |
| 04/27/2000 | WO2000023099A1 Insulin preparations for pulmonary delivery containing menthol |
| 04/27/2000 | WO2000023098A1 Stable concentrated insulin preparations for pulmonary delivery |
| 04/27/2000 | WO2000023086A2 Buffered compositions for dialysis |
| 04/27/2000 | WO2000023079A1 Oral pharmaceutical compositions containing buprenorphin |
| 04/27/2000 | WO2000023070A1 Process for purification of solvents useful in the preparation of pharmaceutical compositions |
| 04/27/2000 | WO2000023065A2 Storable active substance concentrate with formoterol |
| 04/27/2000 | WO2000023055A1 Oral pulsed dose drug delivery system |
| 04/27/2000 | WO2000023054A1 Polyvinyl alcohol microspheres, and methods for making and therapeutic uses of the same |
| 04/27/2000 | WO2000023053A2 Artificial antigen-specific cells and related methods |
| 04/27/2000 | WO2000023052A1 Liposome-entrapped topoisomerase inhibitors |
| 04/27/2000 | WO2000023051A1 Aerosol ointment compositions and method of manufacture |
| 04/27/2000 | WO2000023050A1 Propofol composition comprising pentetate |
| 04/27/2000 | WO2000023045A1 Pharmaceutical composition with gastric residence and controlled release |
| 04/27/2000 | WO2000023043A1 Uv protection compositions |
| 04/27/2000 | WO2000023037A1 Two chamber cartridge for atomizers |
| 04/27/2000 | WO2000023023A1 Methods of hydrating mucosal surfaces |
| 04/27/2000 | WO2000023022A1 Method and compositions for in situ formation of protective and/or medicated films on body tissue |
| 04/27/2000 | WO2000003744A3 Adjuvant and vaccine compositions containing monophosphoryl lipid a |
| 04/27/2000 | WO2000003683A3 Liposomal encapsulated nucleic acid-complexes |
| 04/27/2000 | WO1999065531A9 Polymers for delivery of nucleic acids |
| 04/27/2000 | WO1999065460A3 Pressurized metered dose inhalers and pharmaceutical aerosol formulations comprising a beta-agonist |
| 04/27/2000 | WO1999064073A9 Recombinant immunotoxin directed against the hiv-1 gp120 envelope glycoprotein |
| 04/27/2000 | WO1999063933A9 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 04/27/2000 | WO1999059545A9 Targeted liposomal drug delivery system |
| 04/27/2000 | CA2773698A1 Adjuvant systems comprising an immunostimulant adsorbed to a metallic salt particle and vaccines thereof |
| 04/27/2000 | CA2347369A1 Minimal promoters and uses thereof |
| 04/27/2000 | CA2347118A1 Propofol composition comprising pentetate |
| 04/27/2000 | CA2347108A1 Aerosol ointment compositions and method of manufacture |
| 04/27/2000 | CA2347045A1 Photosensitizer conjugates for targeting intracellular pathogens |
| 04/27/2000 | CA2346969A1 Stable concentrated insulin preparations for pulmonary delivery |
| 04/27/2000 | CA2346884A1 Insulin preparations for pulmonary delivery containing menthol |
| 04/27/2000 | CA2346879A1 Liposome-entrapped topoisomerase inhibitors |